Hereditary haemorrhagic telangiectasia (HHT) is a vascular dysplasia inherited as an
autosomal dominant trait and caused by loss-of-function pathogenic variants in genes …

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease that
manifests as vascular malformations in the brain, lung, liver, gastrointestinal tract, nasal …

Hereditary haemorrhagic telangiectasia (HHT) is a complex, multisystemic vascular
dysplasia affecting approximately 85,000 European Citizens. In 2016, eight founding centres …

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia.
Care delivery for HHT patients is impeded by the need for laborious, repeated phenotyping …

Hereditary haemorrhagic telangiectasia (HHT) is a rare vascular multisystemic disease that
leads to epistaxis, anaemia due to blood loss, and arteriovenous malformations (AVMs) in …

IN RESPONSE: As leaders of the International HHT Guidelines process, we appreciate the
opportunity to respond to the comment from our colleague Prof. Dr. med. Geisthoff on 2 …

The abnormal vascular structures of hereditary hemorrhagic telangiectasia (HHT) often
cause severe anemia due to recurrent hemorrhage, but HHT causal genes do not predict the …

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disease
characterized by the development of vascular malformations (VMs) in organs such as the …

Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu–Osler–Weber Syndrome (ROW) is
an autosomal dominant vascular disease, with an estimated prevalence of 1: 5000. Genes …

BACKGROUND: Hereditary hemorrhagic telangiectasia is an autosomal dominant vascular
dysplasia characterized by mucocutaneous telangiectasias, recurrent epistaxis, and organ …